Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2023GutOpen Access

Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 + T cells

View Full Paper
Ask AI
Bookmark
Share

Authors

XKXing KangNanyang Technological UniversityCLChangan LiuChinese University of Hong KongYDYanqiang DingNingbo University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kang et al. (2023) studied this question.

synapsesocial.com/papers/69737b7f5050f38cfa0dbecahttps://doi.org/10.1136/gutjnl-2023-330291
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer statistics, 20222022 · 18,377 citations
  2. 2Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota2015 · 3,528 citations
  3. 3Dynamic Post-Transcriptional Events Governing CD8+ T Cell Homeostasis and Effector Function2020 · 73 citations
  4. 4Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade2017 · 6,831 citations
  5. 5Computer Review of ChemDraw Ultra 12.02011 · 299 citations